<DOC>
	<DOCNO>NCT01923064</DOCNO>
	<brief_summary>The purpose randomize study compare effect endoscopic injection mixture cyanoacrylate lipiodol versus cyanoacrylate lauromacrogol gastric varix .</brief_summary>
	<brief_title>Injection Cyanoacrylate+Lipiodol v Cyanoacrylate+Lauromacrogol Gastric Varices</brief_title>
	<detailed_description>Gastroesophageal variceal bleed know one frequent death cause patient portal hypertension . When patient bleeding episode , prophylactic treatment give , 's likely he/she develop another rebleeding event future maybe terminal event . Gastric varix occur 18-70 % patient portal hypertension , appear severe , require transfusion high mortality rate esophageal variceal bleeding , high rate rebleeding ( 38-89 % ) . It recommend use endoscopic cyanoacrylate injection first line treatment hemostasis secondary prophylaxis gastric varix general consensus . However , efficacy prevalence complication mixture cyanoacrylate + lipiodol cyanoacrylate + lauromacrogol yet explore report . We conduct study evaluate effect endoscopic injection mixture cyanoacrylate lipiodol versus cyanoacrylate lauromacrogol gastric varix .</detailed_description>
	<mesh_term>Varicose Veins</mesh_term>
	<mesh_term>Hypertension , Portal</mesh_term>
	<mesh_term>Esophageal Gastric Varices</mesh_term>
	<mesh_term>Ethiodized Oil</mesh_term>
	<criteria>Patients present hospital acute gastric variceal bleeding , without liver cirrhosis . The age patient range 18 80 year old . Patients contraindication cyanoacrylate , lipiodol lauromacrogol therapy . Patients abnormal portosystemic shunt accord image result . Patients previous upper gastrointestinal bleeding history . Patients multiple endoscopic treatment esophagogastric varix .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>